| HOME >> MEDICINE >> TECHNOLOGY |
Figure 44: Colorectal Cancer Therapeutics Market, Global, Licensing Agreements by Geography (%), 2010
Figure 45: Colorectal Cancer Therapeutics Market, Global, Licensing Agreements by Screening/Diagnostic Technology (%), 2010
Figure 46: Colorectal Cancer Therapeutics Market, France, Aflibercept Sales Forecast ($m), 2011-2020
Figure 47: Colorectal Cancer Therapeutics Market, Global, Brivanib Chemical Structure, 2010
Figure 48: Colorectal Cancer Therapeutics Market, France, Brivanib Sales Forecasts ($m), 2013-2020
Figure 49: Colorectal Cancer Therapeutics Market, France, OncoVAX Sales Forecast ($m), 2011-2020
Figure 50: Colorectal Cancer Therapeutics Market, France, TroVax Sales Forecast ($m), 2014-2020
Figure 51: Colorectal Cancer Therapeutics Market, Global, Perifosine Chemical Structure, 2010
Figure 52: Colorectal Cancer Therapeutics Market, Global, Median Overall Survival for Metastatic Colorectal Cancer Patients (months), 2010
Figure 53: Colorectal Cancer Therapeutics Market, Global, Opportunity and Unmet Need, 2010
Figure 54: Colorectal Cancer, Global, Key Events Impacting the Future Market
Figure 55: Colorectal Cancer Therapeutics Market, Global, Implications for Future Market Competition, 2010
Figure 56: Colorectal Cancer Therapeutics Market, Global, Merger and Acquisition Deals by Geography, 2010
Figure 57: Colorectal Cancer Therapeutics Market, Global, Merger and Acquisition Deals by Geography (%), 2010
Figure 58: Colorectal Cancer Therapeutics Market, Global, Merger and Acquisition Deals by Deal Size (%), 2010
Figure 65: GlobalData Market Forecasting Model
To order this report:Drug and Medication Industry:
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |